Suvretta Capital Management, LLC 13D and 13G filings for Abeona Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-13 7:53 pm Sale | 2025-06-30 | 13G | Abeona Therapeutics Inc. ABEO | Suvretta Capital Management, LLC | 2,676,000 5.200% | -1,009,503 (-27.39%) | Filing |
| 2024-05-13 5:03 pm Purchase | 2024-05-03 | 13G | Abeona Therapeutics Inc. ABEO | Suvretta Capital Management, LLC | 3,685,503 9.300% | 3,685,503 (New Position) | Filing |